GLG News by Cardiologists who Implant Guidant ICDs (US)
Request a free trial
May 20, 2008
A new drug that would change the way we treat Atrial Fibrillation!
Analysis of: Landmark ATHENA Study findings with dronedarone presented during the annual Heart Rhythm meeting in San Francisco | www.medscape.com
Author: Nassir Marrouche, Director of Cardiac Electrophysiology Laboratories, University of Utah Health Sciences Center
A new drug that would change the way we treat Atrial Fibrillation!
Analysis of: Landmark ATHENA Study findings with dronedarone presented during the annual Heart Rhythm meeting in San Francisco | www.medscape.com
Author: Nassir Marrouche, Director of Cardiac Electrophysiology Laboratories, University of Utah Health Sciences Center
Atrial fibrillation management. New anti-arrhythmic medication.
March 5, 2008The Future of Stereotaxis
Analysis of: Stereotaxis shares tank on Q4 loss | www.24x7mag.com
Author: Brian Olshansky, Professor of Medicine, University of Iowa Hospitals and Clinics
The development of the new technology related to Stereotaxis has been slow going.
While there is much hope there is also much hype.
It is not clear that Stereotaxis really adds much to the success of catheter ablation of atrial fibrillaiton.
There has been a vocal minority...
October 18, 2007Medtronic - the new Guidant?
Analysis of: Medtronic Pulls Heart Device Wires | www.thestreet.com
Author: Daniel Weiss, Chief Medical Officer, Vicor Technologies, Inc.
The current recall is yet another in the world of cardiac rhythm devices. The ICD market is already shakey and may be adversely affected. Will Medtronic's reputation suffer?
October 17, 2007
Another ICD Related Recall - The Medtronic Fidelis ICD Lead: Increase in Fractures
Analysis of: Patients Warned as Maker Halts Sale of Heart Implant Part | www.nytimes.com
Author: GLG Expert Contributor
Analysis of: Patients Warned as Maker Halts Sale of Heart Implant Part | www.nytimes.com
Author: GLG Expert Contributor
With the industry still struggling to recover from the relatively recent Guidant ICD recalls it is possible that this latest ICD lead recall will affect overall ICD implant rates. It is also possible that Medtronic, the leader in the ICD market, will suffer a loss of market share due to this latest...
September 17, 2007TB-402 - the type of anticoagulant patients and physicians are looking for as a warfarin replacement
Analysis of: ThromboGenics and BioInvent Announce Successful Completion of Phase I Clinical Trial of the Anticoagulant TB-402 | www.pipelinereview.com
Author: Daniel Weiss, Chief Medical Officer, Vicor Technologies, Inc.
TB-402 is a new anticoagulant candidate that seeks to fill a desperate unmet need in a variety of different medical conditions. It would be easily administered with a low risk of patient noncompliance, have reversible effects, and potentially safer than currently available alternatives.
August 28, 2007
Medical Tourism
Analysis of: American's Gamble for Bargain Surgery Abroad | www.medpagetoday.com
Author: GLG Expert Contributor
Analysis of: American's Gamble for Bargain Surgery Abroad | www.medpagetoday.com
Author: GLG Expert Contributor
Medical Tourism is purely linked to lower costs for the same procedure.Most of these relate to
1)Small elective surgeries
2) Non-Urgent Cardiac and Non-Cardiac Procedures and Operations
3)Cosmetic Procedures
4)Dental and Vision corrective procedures
5)Radiologic Procedures(Diagnostic and Ther...
August 28, 2007
Angio-seal today-SS
Analysis of: St. Jude Medical Announces Japanese Approval Of The Angio-Seal STS Plus Vascular Closure Device | www.medicalnewstoday.com
Author: GLG Expert Contributor
Analysis of: St. Jude Medical Announces Japanese Approval Of The Angio-Seal STS Plus Vascular Closure Device | www.medicalnewstoday.com
Author: GLG Expert Contributor
The key implications remain
1)Safety
2)Efficacy
3)Cost
4)Complications
e)Outcome analysis
August 9, 2007
A 3-tiered healthcare system
Analysis of: MDs offer new services, for $3,600 yearly fee | www.boston.com
Author: GLG Expert Contributor
Analysis of: MDs offer new services, for $3,600 yearly fee | www.boston.com
Author: GLG Expert Contributor
1) Healthcare in America is becoming a 3 tiered system the insured, the uninsured and the insured "plus" 2) Most definitive care in the US is performed by specialists 3) NPs and PAs can perform the role of PCP for most patients.
May 11, 2007
remote monitoring will assist with tele-medicine in the field of arrhythmias
Analysis of: Remote Patient Monitoring and Disease Management Solutions Key to Promoting Growth in U.S. Tele-Health Solutions Market | sev.prnewswire.com
Author: GLG Expert Contributor
Analysis of: Remote Patient Monitoring and Disease Management Solutions Key to Promoting Growth in U.S. Tele-Health Solutions Market | sev.prnewswire.com
Author: GLG Expert Contributor
Remote monitoring is one of the most important areas of development in the field of cardiac arrhythmias and will play an important role in the field of tele-medicine. The applies to the cardiac rhythm management market as well as the diagnostic market. In the field of cardiac rhythm management, all...
May 1, 2007
TRA assessment
Analysis of: Schering-Plough Announces Initiation Of Two Phase III Clinical Trials For Novel Selective Antiplatelet Therapy (TRA-SCH 530348) | www.medicalnewstoday.com
Author: GLG Expert Contributor
Analysis of: Schering-Plough Announces Initiation Of Two Phase III Clinical Trials For Novel Selective Antiplatelet Therapy (TRA-SCH 530348) | www.medicalnewstoday.com
Author: GLG Expert Contributor
Three key points1) Large unmet need2) Need to assess efficacy against current available treatment3) Safety issues need to be clarified.
Page : 1 2 Next1 to 10 of 14
More GLG News in
Healthcare
Most Popular:
Source Article | Expert Analyses
Use of Antipsychotics in Children Is Criticized
www.nytimes.com
Scientists recommend 'black box' for Avastin
www.fiercepharma.com
Are Costly Diabetes Pills Doing Any Good?
www.pharmalot.com
How a Drug Maker Tries to Outwit Generics
online.wsj.com
Use of Antipsychotics in Children Poses Risks of Adverse Effects
November 26, 2008
Avastin and clots? News to me. Black box warning? Why?
November 24, 2008
Off Label Use Can Be Prevented
November 24, 2008
Gardasil will most certainly be approved for boys
November 24, 2008
Medivations's (MDVN) Dimebon - We've Seen This Movie Before
November 24, 2008

